Abbey Donnell, founder and CEO of Work & Mother, shares how the pandemic's return-to-work policies are affecting new moms. Courtesy of Work & Mother

Consensus seems to indicate that working from home has proven more effective than previously believed, though most would also agree that there is still a need for an office outside the home.

By now, I've received about a million different emails with guides on how to reopen businesses safely amidst COVID-19: how to protect employees, social distancing in the workplace, the future of office space and the effects on commercial real estate…the list goes on and on.

The majority of these guidelines include some version of:

Employers should discontinue use of common spaces such as lunchrooms, breakrooms, meeting rooms and other gathering spaces to avoid unnecessary person-to-person exposure.

This is surely wise. After all, the place with the most germs in the office is usually the faucet of the break room sink.

However, what these recommendations have all failed to consider, what not a single one has even mentioned, is the mother's room.

The majority of mother's rooms, unfortunately, double as some sort of communal wellness or other multi-purpose room. This should not be the case even during non-pandemic times, for a variety of reasons, which you can read about here. But now with COVID-19, for obvious reasons they should not be one and the same. There is a real issue at hand — one with long lasting repercussions for not only working mothers, but their employers too.

The majority of in-office mother's rooms do not have a sink. Therefore, women are forced to carry their used pump parts to the break room or bathroom sink, exposing themselves not only to scrutiny and often even harassment, but also to germs. So, what happens if this common area break room, this already subpar solution, is closed? What do mothers do then?

What about the cleaning and sanitizing of the room? What about room usagee schedules to ensure proper distancing and cleaning between each use? What about including not only hand sanitizer and surface disinfectant wipes, but also the proper pump part cleaning and sanitizing supplies?

What if the mother's room itself is closed, as that too is considered a "communal space?" (Though let us not forget that there are federal and state requirements for the majority of employers to provide a mother's room.)

Fortunately, many offices are implementing more flexible work policies, allowing many to work from home. But, I worry that this "option" will end up becoming a forced "solution" for working mothers. Oh, you're pumping? Just stay home.

On the one hand, great! If you're lucky enough to have in-home childcare, you will actually be able to take breaks and breastfeed your baby. Win! Even if your little one is in daycare, you can at least pump in the privacy of your own home. Win!

However, here's the problem: This approach may actually hurt women's careers and exacerbate the already brutal motherhood penalty. When an employee works completely remotely, particularly if their job isn't intended to be fully remote, or the rest of their team isn't remote, there are serious side effects:

Passed up for promotions and projects
Sometimes this occurs intentionally: "Oh, she shouldn't work on this because it requires in-office time so we'll assign it to someone else." Sometimes it's unintional — simply, out of sight out of mind. If some members of the team are in the office and others aren't, those who are not there often miss casual conversations or spur of the moment brainstorming sessions that leave them behind and in the dark.

Cessation of learning
When cut off from the rest of the team, it's hard to be exposed to learning opportunities. As soon as the learning and growing stops, the dissatisfaction, restlessness, and turnover begins.

Loss of fidelity
Without contact with the rest of the team or organization, we often lose the connection to our cause. We could be working for anyone. Loyalty suffers when there isn't a meaningful connection.

Loss of leadership
Most experts agree that 70 to 93 percent of all communication is nonverbal. Leadership and culture is often most effectively conveyed via modeling behavior. How do you grow your next generation of leaders if they can't see leadership behavior for themselves?

The turnover rate for new mothers is already high — 43 percent — despite the fact that over 75 percent of women want to remain in the workforce to remain in the workforce after becoming mothers, according to an April 2013 article in The Atlantic. This should signal to all employers that they are failing at providing the proper facilities and support for new mothers returning to work. So, what happens when we close the already lacking mother's resources?

This isn't just a women's issue. It's a business issue. Replacing an experienced employee who leaves after childbirth can cost anywhere from 20 to 213 percent of the employee's annual salary. Companies with at least 30 percent management positions held by women tend to be 15 percent more profitable than those without.

Companies such as Goldman Sachs have taken note. They now require at least one woman on the boards of their companies before they can go public. Therefore, employers need to ensure that they can keep top female talent beyond childbearing years. It's worth nothing that according to the CDC, birthrates in the US are declining for all age brackets with the exception of slight gains for women in their 30s and 40s. Meaning, women are waiting longer, until they're more established in their careers, to begin having children. Translation to employers: a more valuable employee you're at risk to lose.

Now, let me be clear about something: I am NOT advocating for a full return to the office for strict, structured working hours. Nor am I saying that women need to run right back to the office right after delivery. Quite the contrary. In fact, I am a firm believer in better parental leave policies and general workplace flexibility with the option of working remotely.

I believe flexibility is actually the very key to leveling the playing field for working mothers. However, to assume that the mother's room is no longer necessary because moms can just stay home, is discrimination, plain and simple. It's the same assumption that's been setting women back for years. "Oh, she probably wants to have kids soon, so she won't want this promotion that will require travel." Or, "oh she's probably just going to get pregnant and quit so I'm not going to hire her."

If a mom chooses to work from home but needs to come in for a meeting, for example, there still needs to be a safe, appropriate facility for her. At a minimum, organizations must create a protocol for this. It is not the mother's job to advocate for this. It is the employer's responsibility to proactively provide for it. This should be an active conversation with landlords.

If mother's needs are not part of this vital return to work safety conversation, women may be left behind. So let's start the conversation.

------

Abbey Donnell is a lactation counselor and the founder and CEO of Work & Mother.

A Houston mom is working hard on her startup so that next summer, breastfeeding moms can swim in style and worry free. Courtesy of Orolait

New mom-designed swimwear line makes a splash in Houston

mommy made

Houston mom Ana Carolina Rojas Bastidas feels there's been an oversight in the fashion industry when it comes to women who are in the breastfeeding stage of motherhood. With her new swimwear line, she hopes to spark a movement for women's fashion.

Bastidas, founder and CEO of Orolait, launched the swimwear line in September 2018 specifically for breastfeeding individuals. Orolait, which floats the tagline "by a mama for mamas," aims to give breastfeeding individuals back the dignity they deserve with bathing suit options.

"I decided to build this company to challenge and change the way we depict one's breastfeeding journey," Bastidas says on the website. "I stand on the pillars of advocacy, education, and inclusion. You will see the sizing and advertising featuring all shapes, sizes, and shades because each of us is so different and that is what makes us so incredible and I am going to unapologetically celebrate that in the most ethical way I know how."

Bastidas, originally from Bogota, Colombia, has been blogging about postpartum body positivity on her platform PowerToPrevail since 2015, sharing her personal journey with her children.

"I was spending a lot of time by the pool and water parks with my two older children," her website states. "I had a big fear of public breastfeeding, but I had a life to live and memories to make with my kids."

Orolait currently offers four different types of bathing suits, each designed to make breastfeeding easier. The suits range from $36 per piece to $72 for a full suit. The suits are designed manufactured by MIYH Design Services, a local business owned by adjunct Art Institute of Houston professor David Dang.

Bastidas tells InnovationMap that she noticed the need for specifically designed suits after experiencing discomfort herself, explaining that traditional suits were not accommodating for swollen milk ducts with the cut and wiring. Bastidas surveyed mothers across all walks of life to see what they struggled with when finding a bathing suit and found that the list was endless. She tells InnovationMap that they got 100 responses in three days.

Her survey found that moms worried about body image, functionality, confidence, feeling fashionable, and comfort, all when looking for a bikini. It became clear to Bastidas that the current market was not working for moms and causing even more stress.

"Our goal is not to be modest," says Bastidas. "I don't believe in modesty when it comes to breastfeeding, but I do believe that people are at different levels and we need to meet them where they are at."

This past November, Orolait launched their first-ever equity crowdfunding campaign through LetsLaunch, a platform based out of Houston, with a goal of raising $250,000. The company reached 10 percent of its goal within its first few days of going life.

"Our goal is to help women who decide that breastfeeding is a journey that they would like to take, to be able to take that journey," says Bastidas. "There are so many obstacles that are already in our way biologically, that to have a lack of product be the reason why you become so discouraged is unacceptable."

Bastidas tells InnovationMap that her goal for the company is to eventually expand offerings in addition to bathing suits and move into brick and mortar retail spaces. She hopes that Orolait will be a representation of all varieties of breastfeeding journeys.

"We want to make sure we represent those moms who are never represented," says Bastidas.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Greentown Labs names Lawson Gow as its new Houston leader

head of hou

Greentown Labs has named Lawson Gow as its Head of Houston.

Gow is the founder of The Cannon, a coworking space with seven locations in the Houston area, with additional partner spaces. He also recently served as managing partner at Houston-based investment and advisory firm Helium Capital. Gow is the son of David Gow, founder of Energy Capital's parent company, Gow Media.

According to Greentown, Gow will "enhance the founder experience, cultivate strategic partnerships, and accelerate climatetech solutions" in his new role.

“I couldn’t be more excited to join Greentown at this critical moment for the energy transition,” Gow said in a news release. “Greentown has a fantastic track record of supporting entrepreneurs in Houston, Boston, and beyond, and I am eager to keep advancing our mission in the energy transition capital of the world.”

Gow has also held analyst, strategy and advising roles since graduating from Rice University.

“We are thrilled to welcome Lawson to our leadership team,” Georgina Campbell Flatter, CEO of Greentown Labs, added in the release. “Lawson has spent his career building community and championing entrepreneurs, and we look forward to him deepening Greentown’s support of climate and energy startups as our Head of Houston.”

Gow is the latest addition to a series of new hires at Greentown Labs following a leadership shakeup.

Flatter was named as the organization's new CEO in February, replacing Kevin Dutt, Greentown’s interim CEO, who replaced Kevin Knobloch after he announced that he would step down in July 2024 after less than a year in the role.

Greentown also named Naheed Malik its new CFO in January.

Timmeko Moore Love was named the first Houston general manager and senior vice president of Greentown Labs. According to LinkedIn, she left the role in January.

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Houston foundation grants $27M to support Texas chemistry research

fresh funding

Houston-based The Welch Foundation has doled out $27 million in its latest round of grants for chemical research, equipment and postdoctoral fellowships.

According to a June announcement, $25.5 million was allocated for the foundation's longstanding research grants, which provide $100,000 per year in funding for three years to full-time, regular tenure or tenure-track faculty members in Texas. The foundation made 85 grants to faculty at 16 Texas institutions for 2025, including:

  • Michael I. Jacobs, assistant professor in the chemistry and biochemistry department at Texas State University, who is investigating the structure and thermodynamics of intrinsically disordered proteins, which could "reveal clues about how life began," according to the foundation.
  • Kendra K. Frederick, assistant professor in the biophysics department at The University of Texas Southwestern Medical Center, who is studying a protein linked to Parkinson’s disease.
  • Jennifer S. Brodbelt, professor in chemistry at The University of Texas at Austin, who is testing a theory called full replica symmetry breaking (fullRSB) on glass-like materials, which has implications for complex systems in physics, chemistry and biology.

Additional funding will be allocated to the Welch Postdoctoral Fellows of the Life Sciences Research Foundation. The program provides three-year fellowships to recent PhD graduates to support clinical research careers in Texas. Two fellows from Rice University and Baylor University will receive $100,000 annually for three years.

The Welch Foundation also issued $975,000 through its equipment grant program to 13 institutions to help them develop "richer laboratory experience(s)." The universities matched funds of $352,346.

Since 1954, the Welch Foundation has contributed over $1.1 billion for Texas-nurtured advancements in chemistry through research grants, endowed chairs and other chemistry-related ventures. Last year, the foundation granted more than $40.5 million in academic research grants, equipment grants and fellowships.

“Through funding basic chemical research, we are actively investing in the future of humankind,” Adam Kuspa, president of The Welch Foundation, said the news release. “We are proud to support so many talented researchers across Texas and continue to be inspired by the important work they complete every day.”

New Houston biotech co. developing capsules for hard-to-treat tumors

biotech breakthroughs

Houston company Sentinel BioTherapeutics has made promising headway in cancer immunotherapy for patients who don’t respond positively to more traditional treatments. New biotech venture creation studio RBL LLC (pronounced “rebel”) recently debuted the company at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Rima Chakrabarti is a neurologist by training. Though she says she’s “passionate about treating the brain,” her greatest fervor currently lies in leading Sentinel as its CEO. Sentinel is RBL’s first clinical venture, and Chakrabarti also serves as cofounder and managing partner of the venture studio.

The team sees an opportunity to use cytokine interleukin-2 (IL-2) capsules to fight many solid tumors for which immunotherapy hasn't been effective in the past. “We plan to develop a pipeline of drugs that way,” Chakrabarti says.

This may all sound brand-new, but Sentinel’s research goes back years to the work of Omid Veiseh, director of the Rice Biotechnology Launch Pad (RBLP). Through another, now-defunct company called Avenge Bio, Veiseh and Paul Wotton — also with RBLP and now RBL’s CEO and chairman of Sentinel — invested close to $45 million in capital toward their promising discovery.

From preclinical data on studies in mice, Avenge was able to manufacture its platform focused on ovarian cancer treatments and test it on 14 human patients. “That's essentially opened the door to understanding the clinical efficacy of this drug as well as it's brought this to the attention of the FDA, such that now we're able to continue that conversation,” says Chakrabarti. She emphasizes the point that Avenge’s demise was not due to the science, but to the company's unsuccessful outsourcing to a Massachusetts management team.

“They hadn't analyzed a lot of the data that we got access to upon the acquisition,” explains Chakrabarti. “When we analyzed the data, we saw this dose-dependent immune activation, very specific upregulation of checkpoints on T cells. We came to understand how effective this agent could be as an immune priming agent in a way that Avenge Bio hadn't been developing this drug.”

Chakrabarti says that Sentinel’s phase II trials are coming soon. They’ll continue their previous work with ovarian cancer, but Chakrabarti says that she also believes that the IL-2 capsules will be effective in the treatment of endometrial cancer. There’s also potential for people with other cancers located in the peritoneal cavity, such as colorectal cancer, gastrointestinal cancer and even primary peritoneal carcinomatosis.

“We're delivering these capsules into the peritoneal cavity and seeing both the safety as well as the immune activation,” Chakrabarti says. “We're seeing that up-regulation of the checkpoint that I mentioned. We're seeing a strong safety signal. This drug was very well-tolerated by patients where IL-2 has always had a challenge in being a well-tolerated drug.”

When phase II will take place is up to the success of Sentinel’s fundraising push. What we do know is that it will be led by Amir Jazaeri at MD Anderson Cancer Center. Part of the goal this summer is also to create an automated cell manufacturing process and prove that Sentinel can store its product long-term.

“This isn’t just another cell therapy,” Chakrabarti says.

"Sentinel's cytokine factory platform is the breakthrough technology that we believe has the potential to define the next era of cancer treatment," adds Wotton.